{"id":156908,"date":"2025-06-13T00:00:00","date_gmt":"2025-06-13T00:00:00","guid":{"rendered":"https:\/\/medgoo.com\/index.php\/2025\/06\/13\/survival-up-for-cabg-with-surgical-ablation-in-atrial-fibrillation\/"},"modified":"2025-06-17T15:10:30","modified_gmt":"2025-06-17T15:10:30","slug":"survival-up-for-cabg-with-surgical-ablation-in-atrial-fibrillation","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2025\/06\/13\/survival-up-for-cabg-with-surgical-ablation-in-atrial-fibrillation\/","title":{"rendered":"Survival Up for CABG With Surgical Ablation in Atrial Fibrillation"},"content":{"rendered":"<h3>\n<p>Medicare beneficiaries undergoing concomitant surgical ablation have risk-adjusted median survival advantage<\/p>\n<\/h3>\n<p><b>By Elana Gotkine HealthDay Reporter<\/b><br \/>\n<b><\/b><\/p>\n<p>FRIDAY, June 13, 2025 (HealthDay News) &#8212; Medicare beneficiaries with preexisting atrial fibrillation undergoing coronary artery bypass grafting (CABG) who undergo concomitant surgical ablation have a survival advantage, according to a study published online June 3 in the <em>Annals of Thoracic Surgery<\/em>.<\/p>\n<p>Justin M. Schaffer, M.D., from Baylor Scott &amp; White &#8211; The Heart Hospital in Plano, Texas, and colleagues identified 87,699 Medicare beneficiaries with preexisting atrial fibrillation undergoing CABG, with or without concomitant surgical ablation, from 2008 to 2019. All-cause mortality and stroke incidence were assessed as separate end points. Overlap propensity score weighting adjusted for measured confounding variables.<\/p>\n<p>Overall, 22.2 percent of the beneficiaries with atrial fibrillation undergoing CABG underwent concomitant surgical ablation. During CABG, 1,193, 1,834, and 652 surgeons infrequently, occasionally, and frequently performed ablation, respectively (&lt;5 percent, \u22655 but &lt;40 percent, and \u226540 percent, respectively). The researchers found that in an as-treated analysis, beneficiaries undergoing surgical ablation had a risk-adjusted median survival advantage of 4.40 months compared to those without (7.82 versus 7.46 years, respectively). The risk-adjusted median survival advantage was 4.96 months for beneficiaries undergoing CABG by surgeons who frequently ablate versus those who infrequently ablate (7.03 versus 6.62 years).<\/p>\n<p>&#8220;This study is one of several recent analyses suggesting that surgical ablation may meaningfully improve survival in patients with preexisting atrial fibrillation undergoing CABG,&#8221; Schaffer said in a statement. &#8220;Our analysis found that the treatment effect of surgical ablation for atrial fibrillation manifested late, over two years after CABG.&#8221;<\/p>\n<p><a href=\"https:\/\/www.annalsthoracicsurgery.org\/article\/S0003-4975(25)00339-X\/abstract\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><i><\/i><br \/>\n<i>Copyright &#169; 2025 <a href=\"https:\/\/consumer.healthday.com\/\" target=\"_new\" rel=\"noopener\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Medicare beneficiaries undergoing concomitant surgical ablation have risk-adjusted median survival advantage<\/p>\n","protected":false},"author":6,"featured_media":157883,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-156908","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/156908","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=156908"}],"version-history":[{"count":0,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/156908\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/157883"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=156908"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=156908"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=156908"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}